EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intensity-controlled Raster Scanning Carbon Ion Radiation Therapy With a Heavy-ion Gantry: Clinical Experience at Heidelberg Ion Beam Therapy Center

Katharina Dvornikovich, Thomas Held, Henrik Franke, Cihangir Cakir, Leonhard Dörsam, Till Manzey, Ziqi Cathy Jiang, Stella Winter, Mia Sittinger, Marcus Winter, Malte Ellerbrock, Thomas Haberer und 5 weitere

International Journal of Radiation Oncology*Biology*Physics · 2026-12 · 126 (5) · 1804-1815

DOI: 10.1016/j.ijrobp.2026.09.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-12. Verfasst von Katharina Dvornikovich und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Baden-Württemberg, Germany; Heidelberg Institute of Radiation Oncology …. Hauptthemen laut MEDLINE: Heavy Ion Radiotherapy, Neoplasms. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Carbon ions have biophysical advantages over photons, including a finite range, increased relative biological effectiveness, and lowered oxygen dependence. Maximum treatment flexibility is attainable with rotational beam delivery. We report our clinical experience using the carbon-ion gantry at the Heidelberg Ion Beam Therapy Center with intensity-controlled raster scanning capability, focusing on treatment toxicity. METHODS AND MATERIALS: A total of 1622 patients treated using the carbon-ion gantry between 2012 and 2026 were evaluated. Data were analyzed using descriptive statistics. Toxicity analysis was conducted using Common Terminology Criteria of Adverse Events v5.0. RESULTS: The median age preradiation therapy was 59 years (range, 18-91). Most patients had locally advanced tumors (21.8% T4; 11.2% T3) without regional lymph node metastases (45.4% N0). The most common treatment indications were sacrococcygeal tumors (n = 331; 20.4%), followed by tumors of the paranasal sinuses (n = 166; 10.2%) and the spine (n = 121; 7.5%). A total of 486 patients (30.0%) received carbon-ion reirradiation, the most frequent carbon-ion gantry treatment indication viewed across all patients. The most common particle therapy beam-angle number was 2 (range, 1-7). The use of more than 2 beam angles was particularly frequent in tumors of the skull base (45.8%) and the thoracic region (40.0%). High-grade (III and IV) acute and late toxicity rates were 2.4% and 4.2% in primary treatment. Mean numbers of acute and late grade I and II toxicity events per patient were 2.2 (95% confidence interval, 2.0-2.4) and 2.0 (95% confidence interval, 1.7-2.4), respectively. CONCLUSIONS: Carbon-ion radiation therapy using a heavy-ion gantry resulted in favorable toxicity rates in specific indications. Further interdisciplinary research demonstrating the clinical benefit of carbon-ion radiation therapy is required. This study provides more evidence supporting particle therapy facilities and may serve as a foundation for prospective clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heavy Ion RadiotherapyNeoplasmsHumansAged, 80 and overMiddle AgedAgedAdultAdolescentFemaleYoung AdultMaleSpinal NeoplasmsRe-IrradiationParanasal Sinus Neoplasms

Autor:innen und Institutionen

  • Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Baden-Württemberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Baden-Württemberg, Germany; National Center for Tu…
  • Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Baden-Württemberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Baden-Württemberg, Germany.
  • Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Baden-Württemberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Baden-Württemberg, Germany; Heidelberg Ion Beam Th…

Zitieren

APA

Dvornikovich, K., Held, T., Franke, H., Cakir, C., Dörsam, L., Manzey, T., Jiang, Z. C., Winter, S., Sittinger, M., Winter, M., Ellerbrock, M., Haberer, T., Mairani, A., Herfarth, K., Harrabi, S. B., Adeberg, S., & Debus, J. (2026). Intensity-controlled Raster Scanning Carbon Ion Radiation Therapy With a Heavy-ion Gantry: Clinical Experience at Heidelberg Ion Beam Therapy Center. International Journal of Radiation Oncology*Biology*Physics, 126(5), 1804-1815. https://doi.org/10.1016/j.ijrobp.2026.09.003

Vancouver

Dvornikovich K, Held T, Franke H, Cakir C, Dörsam L, Manzey T, et al. Intensity-controlled Raster Scanning Carbon Ion Radiation Therapy With a Heavy-ion Gantry: Clinical Experience at Heidelberg Ion Beam Therapy Center. International Journal of Radiation Oncology*Biology*Physics. 2026;126(5):1804-1815. doi:10.1016/j.ijrobp.2026.09.003

BibTeX
@article{Dvornikovich2026,
  author = {Dvornikovich, Katharina and Held, Thomas and Franke, Henrik and Cakir, Cihangir and Dörsam, Leonhard and Manzey, Till and Jiang, Ziqi Cathy and Winter, Stella and Sittinger, Mia and Winter, Marcus and Ellerbrock, Malte and Haberer, Thomas and Mairani, Andrea and Herfarth, Klaus and Harrabi, Semi B and Adeberg, Sebastian and Debus, Jürgen},
  title = {Intensity-controlled Raster Scanning Carbon Ion Radiation Therapy With a Heavy-ion Gantry: Clinical Experience at Heidelberg Ion Beam Therapy Center},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {5},
  pages = {1804--1815},
  doi = {10.1016/j.ijrobp.2026.09.003}
}
Kostenlos starten →